Palo Alto Investors LP Uro Gen Pharma Ltd. Transaction History
Palo Alto Investors LP
- $856 Million
- Q1 2024
A detailed history of Palo Alto Investors LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Palo Alto Investors LP holds 24,500 shares of URGN stock, worth $411,110. This represents 0.04% of its overall portfolio holdings.
Number of Shares
24,500
Previous 24,500
-0.0%
Holding current value
$411,110
Previous $367,000
-0.0%
% of portfolio
0.04%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
113Shares Held
24MCall Options Held
46.9KPut Options Held
44.3K-
Rtw Investments, LP New York, NY3.26MShares$54.7 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.62MShares$44 Million9.62% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$38.6 Million0.26% of portfolio
-
Black Rock Inc. New York, NY1.72MShares$28.8 Million0.0% of portfolio
-
Cowen And Company, LLC1.63MShares$27.3 Million0.82% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $382M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...